Delivery Order SPE2DB22D2206-SPE2DB25FJV25
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a firm fixed price ceiling value of $6,998.20. The award, executed on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside contract. The contract will be fulfilled from AmerisourceBergen's operations in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 20,000 unit vials of Recothrom (thrombin topical), a hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $7,567.75, was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,136.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a topical thrombin product used in surgical hemostasis. Issued on August 22, 2025, with an ultimate completion date of August 25, 2025, this non-set-aside contract represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC SPE2DX) valued at $999,999,999.00 through December...
- This delivery order, awarded May 12, 2025, obligates $8,481.60 to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. The award is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. Performance will be completed by May 13, 2025, at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, for 20,000 unit vials of Recothrom with a ceiling value of $30,646.93. The contract represents a non-competitive, non-set-aside award with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,032.07 for 20,000 unit vials of RECOTHROM on May 15, 2025, with an ultimate completion date of May 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom on June 2, 2025, with a ceiling value of $28,940.39. This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made without a set-aside designation through competitive procurement, and performance will...
- The Defense Logistics Agency awarded a $5,654 delivery order contract to Amerisourcebergen Drug Corporation to provide 20,000 units of Recothrom thrombin recombinant topical hemostatic agent. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by June 30, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was awarded without a set aside designation. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,688.64 to AmerisourceBergen Drug Corp for 20,000 unit vials of RECOTHROM on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV25Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $25,119.14, was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical prime vendor vehicle for global military healthcare support, enabling AmerisourceBergen to supply specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to fulfill federal medical procurement requirements across multiple therapeutic domains through its competitive contract performance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 9/8/25 |